Are You Looking for a Top Momentum Pick? Why The Pennant Group, Inc. (PNTG) is a Great Choice

Does The Pennant Group, Inc. (PNTG) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research • Sep 21, 2026

The Pennant Group: The Pros Of Investing Continue To Outweigh The Cons

I am maintaining my Buy rating on The Pennant Group driven by robust fundamentals and +200% stock appreciation since April 2023. PNTG delivered 36% revenue growth in 2025 and guides for 25% growth in 2026, with adjusted EPS of $1.34–$1.41 and EBITDA of $94.4–$98M. Strategic acquisitions, disciplined growth, and a culture of operational excellence underpin PNTG's expansion in home health, hospice, and senior living.

Seeking Alpha • Sep 18, 2026

The Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last?

The Pennant Group (PNTG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Investment Research • Sep 17, 2026

Pennant Acquires Real Estate of Mainplace Senior Living in Orange, California

EAGLE, Idaho, Sept. 16, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of Pennant affiliated home health, hospice, home care and senior living companies, announced today that, effective September 3, 2026, it acquired the real estate of Mainplace Senior Living (“Mainplace”), a senior living community located in Orange, California. A Pennant affiliated subsidiary has operated Mainplace under a triple-net lease since our spin-off in 2019. This acquisition aligns with our disciplined approach of capital deployment in acquiring senior living real estate, at attractive pricing, to capture both the long-term value of the real estate that benefits from the strong cultural, clinical and operational results in the acquired community.

GlobeNewsWire • Sep 16, 2026

All You Need to Know About The Pennant Group (PNTG) Rating Upgrade to Buy

The Pennant Group (PNTG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Sep 14, 2026

Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference

EAGLE, Idaho, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Jefferies Healthcare Services Conference on September 15, 2026.

GlobeNewsWire • Sep 1, 2026

The Pennant Group Q2 Earnings Call Highlights

The Pennant Group NASDAQ: PNTG reported second-quarter 2026 results that showed revenue and adjusted earnings growth across its home health, hospice and senior living businesses, prompting the company to raise its full-year outlook.

MarketBeat • Aug 7, 2026

OPCH vs. PNTG: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Option Care (OPCH) and The Pennant Group, Inc. (PNTG). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research • Aug 7, 2026

The Pennant Group, Inc. (PNTG) Q2 2026 Earnings Call Transcript

The Pennant Group, Inc. (PNTG) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 6, 2026

Pennant Reports Second Quarter 2026 Results

EAGLE, Idaho, Aug. 05, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.25 for the second quarter of 2026. Pennant also reported adjusted diluted earnings per share of $0.36 for the quarter(1 ).

GlobeNewsWire • Aug 5, 2026